Management of Hyperkeratosis of the Lower Limb

Share this article

Management of Hyperkeratosis of the Lower Limb

31 August 2014

The purpose of this Best Practice Guidance is to present guidance on the prevention and management of hyperkeratosis of the lower limb.

At present there are no national guidelines for the management of hyperkeratosis. Hyperkeratosis is an increased thickening of the stratum corneum resulting in thickened, scaly skin (International Lymphoedema Framework [ILF], 2012; European Wound Management Association [EWMA], 2005).

Hyperkeratosis can become severe, which can make treatment and adjunctive therapies (e.g. compression) more difficult. However, the condition can be managed effectively given appropriate and timely assessment and treatment.

Supported by Activa

Free for all healthcare professionals

Sign up to the Wounds Group journals

By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.